Erlocip 150 mg (1 pack – 30 tabs) Erlotinib

Buy Erlocip 150 mg (30 Tablets) Erlotinib Online

Erlocip Erlotinib – 150 mg (1 pack / 30 tablets)

At a Glance

Brand name: Erlocip

Generic name: Erlotinib hydrochloride

Active ingredient: Erlotinib

Strength & pack size: Erlocip 150 mg (1 pack / 30 tablets)

Dosage form: Oral film-coated tablets

Main indication: Advanced or metastatic non–small cell lung cancer (NSCLC) and selected pancreatic cancer indications

Therapeutic class: EGFR tyrosine kinase inhibitor

Use in therapy: Targeted first-line or subsequent EGFR-directed therapy in NSCLC and other approved settings

Prescription status: Prescription-only anticancer medicine

Supplied by: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from moisture and light

Product Description

Erlocip 150 mg tablets are a generic erlotinib hydrochloride medicine used as targeted therapy for certain advanced cancers.
Erlotinib is an EGFR tyrosine kinase inhibitor (TKI) that interferes with signalling pathways driving tumour growth,
particularly in advanced non–small cell lung cancer (NSCLC).
Erlocip 150 mg (1 pack / 30 tablets) provides a convenient once-daily strength of erlotinib for patients whose oncologists have recommended EGFR-directed treatment.

Erlocip erlotinib tablets are often used in locally advanced or metastatic NSCLC, especially when tumours harbour activating
EGFR mutations that make them sensitive to EGFR tyrosine kinase inhibition. In some settings,
erlotinib tablets may also be used in pancreatic cancer, according to recognised protocols and specialist judgement.
Because Erlocip is a generic erlotinib product, it contains the same active ingredient as branded erlotinib while offering more accessible pricing in USD.

Each Erlocip 150 mg tablet contains erlotinib hydrochloride equivalent to 150 mg of erlotinib.
Tablets are taken by mouth, usually once daily, and your oncologist may instruct you to take Erlocip on an empty stomach or to avoid certain foods and medicines that alter absorption.
When you buy Erlocip 150 mg online from Generic Meds Mart, you receive medicines from licensed manufacturers and authorised distributors operating under recognised GMP standards.
Discreet outer packaging protects your privacy, while original blisters and cartons preserve full product information.

This Erlocip 150 mg (1 pack / 30 tablets) product is intended only for patients already under specialist oncology care who have been advised to use
erlotinib therapy. Generic Meds Mart does not diagnose cancer or change treatment plans;
the information on this page supports informed discussions with your oncology team about access to generic erlotinib tablets.

Key Uses

Erlocip 150 mg erlotinib tablets are typically used for the following indications under specialist supervision:

• Treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC), especially in EGFR mutation–positive tumours
• First-line, maintenance or subsequent therapy in selected NSCLC patients where EGFR TKI treatment is recommended
• Treatment of certain advanced pancreatic cancer cases, in combination with other agents, where erlotinib is indicated

Your oncologist will determine whether Erlocip 150 mg is appropriate, specify the daily dose and decide how long
erlotinib treatment should continue.

How Erlotinib Works in Chemotherapy

Erlotinib is a targeted anticancer agent often grouped within modern systemic chemotherapy and targeted therapy regimens.
Erlocip contains erlotinib, an EGFR tyrosine kinase inhibitor (TKI) that blocks signalling from the epidermal growth factor receptor.
In many NSCLC tumours, activating EGFR mutations cause continuous signalling and uncontrolled cell growth.

Erlocip erlotinib tablets bind to the intracellular tyrosine kinase domain of EGFR and block ATP binding,
disrupting downstream signalling pathways that promote cancer cell proliferation and survival. In tumours that depend heavily on EGFR signalling,
this can lead to tumour shrinkage or stabilisation. Because erlotinib targets a molecular driver of the cancer rather than all rapidly dividing cells,
its side effect profile differs from traditional cytotoxic chemotherapy, but careful monitoring is still required.

EGFR mutation testing is an important part of deciding whether Erlocip erlotinib is appropriate.
Your oncologist will interpret test results and determine whether an EGFR TKI such as Erlocip fits your overall treatment plan.

Dosage & Administration

Erlocip 150 mg erlotinib tablets must always be taken exactly as prescribed by your oncologist.
Daily dosing, timing and duration of therapy depend on your diagnosis, tumour characteristics, other medicines and response to treatment.

• Take Erlocip tablets by mouth with water; your doctor may instruct you to take them on an empty stomach or at specific times relative to meals.
• Swallow erlotinib tablets whole without crushing, splitting or chewing unless your doctor or pharmacist provides specific instructions.
• Take Erlocip 150 mg once daily at approximately the same time each day, unless your oncologist advises otherwise.
• Do not change your dose, skip doses or stop taking Erlocip without clear guidance from your oncology team.
• If you miss a dose, follow your doctor’s instructions; do not double the next dose unless specifically advised.

Your oncologist will schedule regular visits, blood tests and imaging studies to monitor your response to
Erlocip erlotinib therapy and to adjust the treatment plan if necessary.

Precautions

Before starting Erlocip 150 mg, inform your doctor about your full medical history and all medicines, supplements or herbal products you use. Important considerations include:

• History of lung diseases such as interstitial lung disease, pulmonary fibrosis or other chronic lung conditions
• Liver disease, kidney impairment or significant cardiovascular disease
• Previous severe skin reactions or serious gastrointestinal problems
• Use of medicines that alter stomach acidity (proton pump inhibitors, H2 blockers, antacids)
• Use of CYP3A4 inhibitors or inducers, certain antibiotics, antifungals or antiepileptics that may interact with erlotinib
• Use of anticoagulants, especially warfarin, which may require closer monitoring during Erlocip erlotinib therapy

Erlotinib may not be suitable during pregnancy, and effective contraception is usually recommended during treatment and for a period afterwards, as advised by your doctor.
Breastfeeding is often discouraged while taking Erlocip. Your oncology team will explain which precautions and monitoring tests apply to you.

Erlotinib Side Effects

Common side effects

Many patients experience side effects when starting Erlocip erlotinib tablets, especially during the first weeks of therapy. Common side effects may include:

• Acne-like skin rash, often on the face, scalp or upper trunk
• Dry, itchy or sensitive skin, sometimes with increased sun sensitivity
• Diarrhea or loose stools
• Mild nausea, vomiting or stomach discomfort
• Reduced appetite and weight loss
• Fatigue or general weakness

These effects are often manageable with supportive care, skin protection, diet adjustments or dose modifications.
You should report persistent or troublesome symptoms to your oncology team.

Serious side effects

Some side effects of erlotinib are less common but serious and require urgent medical attention. Serious reactions may include:

• New or worsening shortness of breath, cough or fever that may indicate interstitial lung disease or severe lung inflammation
• Severe or persistent diarrhea with signs of dehydration, such as dizziness, fainting or reduced urine output
• Severe abdominal pain, black or bloody stools or vomiting blood, which may indicate gastrointestinal perforation or bleeding
• Signs of liver problems, including yellowing of the skin or eyes, dark urine, pale stools or intense upper abdominal pain
• Severe skin reactions with widespread rash, blistering, peeling or involvement of the mouth, eyes or other mucous membranes

If you experience any of these serious symptoms while taking Erlocip 150 mg, seek immediate medical care and contact your oncology team as soon as possible.

Storage

• Store Erlocip 150 mg tablets at room temperature, usually below 25 °C, in a dry place away from direct sunlight and excess heat.
• Keep the tablets in their original blisters and carton until use to protect them from moisture and light.
• Keep erlotinib tablets out of the sight and reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Ask your pharmacist or follow local regulations for safe disposal of unused or expired Erlocip erlotinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart focuses on providing reliable access to essential oncology medicines such as
Erlocip 150 mg erlotinib tablets at fair prices in USD.
We work only with licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a documented export track record.

When you buy Erlocip 150 mg online from Generic Meds Mart, you benefit from:

• Competitive pricing on generic erlotinib tablets compared with many local pharmacies
• Discreet, plain packaging designed to protect your privacy during shipping
• Tracked international delivery options to many destinations
• Clear, structured product information to support discussions with your oncologist
• Customer support available to assist with ordering, payment and shipping questions

Our goal is to help you maintain continuity of prescribed targeted therapy with transparent conditions and professional handling of each order.

Order Now

Erlocip 150 mg erlotinib tablets are prescription-only anticancer medicines and must be used strictly under the supervision of an oncologist.
Before you order Erlocip 150 mg online, ensure that you have a valid prescription or written treatment plan specifying erlotinib, the 150 mg strength and the intended duration of therapy.

Select Erlocip 150 mg (1 pack / 30 tablets), choose the appropriate quantity, add Erlocip to your cart and complete the secure checkout process.
Your order will be processed, packed discreetly and shipped with tracking where available.

Generic Meds Mart does not provide diagnosis or personalised medical advice. All treatment decisions, dose changes and monitoring remain the responsibility of your oncology team.

 

Q6: Is Erlocip 150 mg the same as Tarceva (Generic Tarceva)?
Erlocip 150 mg is Generic Tarceva — it contains the same active ingredient (erlotinib) as Tarceva. It’s used for the same purpose at the same strength, while differences may be in manufacturer, inactive ingredients (excipients), tablet appearance, and packaging. If you’re switching between products, confirm the substitution with a qualified healthcare professional.